The pharmaceutical company reached a $100 million settlement in 2017 after the Federal Trade Commission accused the drugmaker of violating antitrust laws to thwart competitors from undercutting …
Mallinckrodt paid ‘kickbacks’ to keep drug price high, and stuck taxpayers with bill, DOJ lawsuit says
Mallinckrodt paid ‘kickbacks’ to keep drug price high, and stuck taxpayers with bill, DOJ lawsuit says
Leave a reply